查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011132

生物刺激剂市场：依形态、原料、应用方法和作物类型划分－2026-2032年全球市场预测

Biostimulants Market by Form, Source, Application Method, Crop Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物刺激剂市场价值将达到 50.6 亿美元，到 2026 年将成长至 56.6 亿美元，到 2032 年将达到 114.7 亿美元，年复合成长率为 12.40%。

主要市场统计数据
基准年 2025 50.6亿美元
预计年份：2026年 56.6亿美元
预测年份 2032 114.7亿美元
复合年增长率 (%) 12.40%

随着监管和商业化需求的不断增长，将生物刺激剂作为提高作物耐受性和营养利用效率的关键工具的趋势日益明显。

生物刺激剂产业正处于转折点，多种因素共同作用，使其在作物综合营养策略中的重要性日益凸显。生物学发现的进步，以及专业种植者和农产品经销商的广泛应用，已使生物刺激剂从小众助剂转变为提高作物抗逆性、养分利用效率和品质的战略工具。同时，不断完善的法规结构和对产品功效的强化监测，提高了基于证据的性能标准和供应链透明度。因此，製造商、合约开发商和服务供应商正在积极应对，透过更严格的产品特性描述、扩展的测试网路以及更清晰的标籤检视，来阐明其作用机制和适用场景。

由科学创新、策略伙伴关係和监管协调驱动的多方面变革正在提高商业性渗透率和营运严谨性。

近年来，在科学日趋成熟、供应链不断发展以及客户期望转变的推动下，生物刺激剂市场格局发生了巨大变化。微生物发现和製剂科学的创新拓宽了种植者可用的功能性投入品范围，从而能够提供客製化的解决方案，以减轻作物胁迫并提高产量和品质。同时，邻近农业材料领域的产业重组以及老牌农药生产商与专业生物技术公司之间的策略合作，正在重塑市场进入通路、分销网络和产品研发资源分配。此外，数位农业和精准施药系统也为透过区域绩效数据和订阅咨询服务展现价值创造了新的机会。

为应对关税带来的成本压力，我们正在透过重组采购、配方和在地化策略来审查我们的业务运营，并展现我们的采购韧性。

美国近期实施的关税措施为生物刺激剂价值链上的所有相关人员带来了新的成本和物流挑战。由于关税导致某些进口原材料和中间投入品的到货成本增加，迫使製造商重新评估筹资策略、库存政策和供应商多元化计划。因此，一些生产商正在加快开发在地采购替代方案，并调整配方以减少对受影响进口产品的依赖。同时，经销商和配方製造商也在审查定价和合约条款，以在保持获利能力的同时，满足对成本敏感的终端用户的竞争需求。

详细的分割分析揭示了作物的形态、生物原料、应用途径和最终用途如何决定技术要求、测试设计和商业化方法。

对产品细分市场的详细分析揭示了每种物理形态、生物来源、应用方法和最终用途作物的不同发展路径和商业性动态。颗粒、液体和粉末状产品各自面临不同的配方挑战和应用场景。颗粒适用于土壤施用和机械化播种；液体可快速吸收，适用于叶面喷布和施肥/灌溉平台；粉末在特定供应链中具有灵活的剂量控制和储存优势。从生物来源的角度来看，胺基酸、腐植酸、微生物製剂、蛋白质水解物和海藻萃取物各自具有独特的作用机制和市场预期。对于腐植酸而言，需要区分富里酸组分和腐植酸成分，以明确其溶解度和与土壤化学性质的相互作用。另一方面，微生物製剂需要清晰的分类学和菌株水平的记录，以明确区分放线菌、细菌、真菌及其目标功能。蛋白质水解物进一步分为两大类：动物源性和植物来源，这会影响辨识、调控途径以及对特定作物系统的适用性。

监管要求、通路和生产​​商优先事项的区域差异决定了各个商业化和证据生成策略。

区域趋势影响着价值的创造地点和商业策略的实施方式，北美、欧洲、中东和非洲以及亚太地区呈现出截然不同的市场动态。在北美，成熟的分销网络和大型商业生产商的存在正在加速生物刺激剂与机械化农业和精准投入系统的结合应用。同时，南北贸易流动影响生物材料在供应链中的定位。在欧洲、中东和非洲，复杂的法规环境，加上强有力的永续发展议程和零售商主导的品质要求，使得拥有清晰环境记录和可追溯供应链的产品更受青睐。相较之下，在亚太地区，农业的快速现代化和农场规模的差异性使得可扩展、低成本的配方方法和本地技术支援对于更广泛的应用至关重要。

企业策略和业务活动透过科学差异化、卓越製造和贯穿整个价值链的管道整合来定义领导地位。

生物刺激剂产业的竞争格局呈现出多元化的态势，既有技术主导的新兴参与企业，也有成熟的农资供应公司和专业服务供应商。技术主导企业通常强调其专有的生物菌株、先进的萃取技术和精准的应用系统，并大力投资测试网路和科学检验，以建立信誉。成熟的农业供应公司则利用其广泛的分销网络、与种植户建立的稳固关係以及整合的商业性服务，将生物刺激剂融入肥料和作物保护产品组合中进行销售。专业的生产商和合约开发人员则专注于配方优化、大规模生产和法规支持，服务对象包括品牌所有者和自有品牌合作伙伴。

将科学创新转化为可靠的农业成果、可扩展的生产和稳健的商业性执行所面临的实际策略挑战。

产业领导者应采取一系列切实可行的措施，将科学潜力转化为可重复的农业化学品价值和商业性吸引力。首先，优先投资进行严谨且可重复的田间试验，试验内容应涵盖不同的农业生态区域和施用方法，以确保产品功效声明的可信度和适用性。其次，根据分销管道的实际情况调整配方开发，设计适用于机械化喷洒、施肥和灌溉系统或零售处理要求的剂型，从而最大限度地减少推广障碍。第三，实现采购管道多元化，加强与供应商的伙伴关係，并鼓励在应对力和成本控制能力更强的地区进行生产，以降低关税和供应中断的风险。

采用透明的混合方法研究设计，结合对关键相关人员的访谈、技术文献的整合和情境评估，确保了研究的合法性和可操作的见解。

支持这些发现的调查方法采用了多阶段方法，兼顾了初步检验和严谨的二次整合。研究人员透过对生产商、经销商、配方专家和研发负责人进行结构化访谈，收集了初步信息，以了解田间实践、推广障碍和证据要件。这些观点与技术文献和同行评审的研究进行了交叉比对，以检验作用机制并了解配方在土壤和叶面环境中的相互作用。此外，研究人员还审查了法规结构和註册指南，以评估其对功效声明和跨境商业化的影响。

策略整合强调以证据为基础的商业化、跨职能协作和业务永续营运，并将这些视为长期成功的决定因素。

总之，生物刺激剂领域的现状呈现出科学成熟、监管要求不断提高以及商业结构不断演变的特点，这些因素共同提升了机会，同时也增加了实施难度。相关人员若能投资于严格的检验、灵活的配方策略和健全的采购体系，将能更有效地获取生物刺激剂在现代作物管理系统中带来的战略价值。此外，研发、监管和商业化团队之间的合作至关重要，只有这样才能将前景广阔的生物学发现转化为种植者信赖并能常规使用的产品。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生物刺激剂市场：依形式划分

  • 颗粒
  • 液体
  • 粉末

第九章：生物刺激剂市场：依来源划分

  • 胺基酸
  • 腐植质
    • 富里酸
    • 腐植酸
  • 微生物来源
    • 放线菌
    • 细菌
    • 真菌
  • 蛋白质水解物
    • 动物源性
    • 植物来源
  • 海藻萃取物

第十章：按应用方法分類的生物刺激剂市场

  • 叶面喷布
  • 种子处理
  • 土壤处理
    • 滴灌
    • 沟施

第十一章：生物刺激剂市场：依作物类型划分

  • 谷类和谷类食品
  • 水果和蔬菜
  • 油籽/豆类
  • 草坪和观赏植物

第十二章：生物刺激剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：生物刺激剂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：生物刺激剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国生物刺激剂市场

第十六章：中国生物刺激剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acadian Seaplants Limited
  • Agricen by Nutrien
  • AgriLife（India）Private Limited
  • Agrinos
  • Agritecno Fertilizantes SL
  • Andermatt Group AG
  • Apple Agro
  • Atlantica Agricola, SA
  • Axeb Biotech SL
  • BASF SE
  • Bayer AG
  • BioAtlantis Ltd.
  • Biobest Group NV
  • BIOIBERICA SAU
  • Biolchim SpA by JM Huber Corporation
Product Code: MRR-43422F546E3C

The Biostimulants Market was valued at USD 5.06 billion in 2025 and is projected to grow to USD 5.66 billion in 2026, with a CAGR of 12.40%, reaching USD 11.47 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.06 billion
Estimated Year [2026] USD 5.66 billion
Forecast Year [2032] USD 11.47 billion
CAGR (%) 12.40%

An integrative orientation that positions biostimulants as critical tools for crop resilience and nutrient efficiency amid heightened regulatory and commercialization demands

The biostimulants sector is at an inflection point, shaped by converging drivers that elevate its importance within integrated crop nutrition strategies. Advances in biological discovery, coupled with growing adoption among professional growers and input distributors, have repositioned biostimulants from niche supplements to strategic tools used to enhance crop resilience, nutrient use efficiency, and quality outcomes. In parallel, evolving regulatory frameworks and increasing scrutiny of product claims have raised the bar for evidence-based performance and supply chain transparency. Consequently, manufacturers, contract developers, and service providers are responding with more rigorous product characterization, expanded trial networks, and clearer labels that articulate modes of action and situational use cases.

Moving from concept to operational deployment, industry participants face the dual challenge of demonstrating consistent agronomic benefits while establishing scalable manufacturing and distribution pathways. This requires a tighter integration of R&D pipelines with commercialization channels so that novel actives and formulations can be validated under real-world conditions. In addition, investment in analytical techniques and biological assays is accelerating, enabling better differentiation among product classes. Given these dynamics, strategic stakeholders should view the current environment as one in which scientific credibility and operational readiness together determine competitive positioning and long-term value creation.

A multifaceted transformation driven by scientific innovation, strategic partnerships, and regulatory harmonization that elevates commercial adoption and operational rigor

The landscape for biostimulants has shifted markedly in recent years, driven by scientific maturation, supply-chain evolution, and shifting customer expectations. Innovations in microbial discovery and formulation science have broadened the palette of functional inputs available to growers, enabling tailored solutions for stress mitigation and yield quality. Meanwhile, consolidation in adjacent agricultural input segments and strategic partnerships between established agrochemical firms and specialist biotech providers are reshaping routes to market, distribution reach, and resource allocation for product development. At the same time, digital agronomy and precision application systems are creating new opportunities to demonstrate value through localized performance data and subscription-based advisory services.

These transformative shifts also encompass the regulatory and commercial environment. Regulators are increasingly focused on standardizing claim substantiation and harmonizing registration pathways, which favors companies that invest in reproducible science and robust field evidence. Additionally, procurement and sourcing strategies are evolving to prioritize traceability, sustainability credentials, and supply continuity, particularly for biologically derived inputs. As a result, organizations that align R&D, regulatory affairs, and commercial functions will be better positioned to capture premium placements and long-term contracts with institutional growers and distributors. In short, the market is moving from early experimentation toward institutional adoption, with competitive advantage accruing to those who can scale validated innovations reliably.

Operational recalibration and sourcing resilience emerging in response to tariff-driven cost pressures that reshape procurement, formulation, and localization strategies

Recent tariff measures introduced by the United States have introduced new cost and logistics considerations for participants across the biostimulants value chain. Tariff-driven increases in the landed cost of certain imported raw materials and intermediate inputs have prompted manufacturers to reassess sourcing strategies, inventory policies, and supplier diversification plans. In consequence, some producers have accelerated development of local supply alternatives or reconfigured formulations to reduce dependency on affected imports. At the same time, distributors and formulators are reevaluating pricing and contract terms to preserve margin while remaining competitive for end users who are sensitive to input costs.

Beyond immediate cost impacts, tariffs have influenced investment decisions and longer-term strategic planning. They have reinforced interest in nearshoring critical manufacturing steps and in vertical integration options that insulate firms from import volatility. Moreover, tariffs have increased the importance of transparent documentation and classification of biological materials to ensure accurate duty treatment and to avoid downstream compliance delays. While tariffs affect multiple nodes across the ecosystem, they also create an impetus for companies to strengthen commercial resilience through multi-sourcing, strategic inventory positioning, and enhanced supplier collaborations. Taken together, these responses reflect a pragmatic recalibration rather than a one-time disruption, with firms embedding tariff risk considerations into procurement and product development roadmaps.

Detailed segmentation analysis revealing how form, biological source, application pathways, and crop end-use determine technical requirements, trial design, and commercialization approaches

A nuanced view of product segmentation reveals distinct development pathways and commercial dynamics for different physical forms, biological sources, application methods, and crop end-uses. Products available as granules, liquids, and powders manifest different formulation challenges and application profiles; granules often align with soil-applied programs and compatibility with mechanized seeding, liquids support foliar and fertigation platforms with rapid uptake, and powders provide flexible dose control and storage advantages for certain supply chains. In terms of biological origin, amino acids, humic substances, microbial inoculants, protein hydrolysates, and seaweed extracts each bring unique modes of action and market expectations. Humic substances demand differentiation between fulvic acid fractions and humic acid constituents to clarify solubility and interaction with soil chemistry, while microbial offerings require clear taxonomy and strain-level documentation that delineates actinomycetes, bacteria, and fungi and their targeted functions. Protein hydrolysates further bifurcate into animal-derived and plant-derived streams, influencing perception, regulatory pathways, and suitability for specific crop systems.

Application method matters as well, with foliar delivery, seed treatments, and soil treatments serving distinct agronomic roles and logistics considerations. Soil-applied products are themselves divided by delivery technique, where drip irrigation integration and furrow application present differing compatibility and adoption profiles across irrigation infrastructures. Finally, crop type segmentation-spanning cereals and grains, fruits and vegetables, oilseeds and pulses, and turf and ornamentals-shapes product claims, trial designs, and channel strategies because grower priorities and crop management rhythms vary significantly. Collectively, these segmentation dimensions suggest that successful commercial approaches will pair precise formulation and evidence with channel-specific commercialization plans that respect the technical constraints and decision drivers of each use case.

Regional differentiation in regulatory requirements, distribution channels, and grower priorities that dictates tailored commercialization and evidence generation strategies

Regional dynamics are influencing where value is created and how commercial strategies are executed, with distinct market mechanics evident across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established distribution networks and a significant presence of large commercial growers accelerate adoption of biostimulants that integrate with mechanized farming and precision input systems, while North-South trade flows affect supply chain positioning for raw biological materials. Europe, Middle East & Africa presents a complex regulatory mosaic alongside strong sustainability agendas and retailer-driven quality requirements that favor products with clear environmental credentials and traceable supply chains. In contrast, Asia-Pacific combines rapid agricultural modernization with heterogeneous farm sizes, producing an environment where scalable, low-cost formulation approaches and local technical support are critical to wider adoption.

These regional distinctions have operational implications. For instance, regulatory compliance pathways and label claims must be adapted to regional authorities and market expectations, which in turn affects evidence generation and labeling strategies. Distribution models also differ; some regions favor direct engagement with large growers and advisory networks, while others rely on robust retail channels and independent distributors. Consequently, companies that tailor commercialization tactics to regional agronomic realities, regulatory frameworks, and channel structures will increase their likelihood of sustained penetration and meaningful growth across diversified geographies.

Corporate strategies and operational behaviors that determine leadership through scientific differentiation, manufacturing excellence, and channel integration across the value chain

Competitive dynamics among companies operating in the biostimulants space reflect a mix of technology-led entrants, incumbent agri-input firms, and specialized service providers. Technology-led firms often emphasize proprietary biological strains, advanced extraction techniques, and targeted application systems, investing heavily in trial networks and scientific validation to build credibility. Incumbent agricultural suppliers leverage broad distribution footprints, established grower relationships, and integrated commercial offerings to bundle biostimulants with fertility and crop protection packages. Specialized manufacturers and contract developers focus on formulation excellence, scale manufacturing, and regulatory support, catering to both branded owners and private-label partners.

Across these archetypes, strategic behaviors converge around several themes: vertical partnerships that secure raw biological inputs and R&D collaborations that accelerate product differentiation, M&A activity that fills capability gaps or expands geographic reach, and enhanced focus on regulatory and claims substantiation to meet evolving standards. Operational excellence in manufacturing and quality control also distinguishes market leaders, as does investment in digital agronomy services that demonstrate practical benefits at the field level. Ultimately, companies that successfully combine scientific rigor, manufacturing reliability, and commercial channel strength will be best positioned to convert technical promise into consistent customer outcomes and durable commercial relationships.

Practical strategic imperatives for converting scientific innovation into reliable agronomic outcomes, scalable manufacturing, and resilient commercial execution

Industry leaders should adopt a pragmatic set of actions that translate scientific potential into reproducible agronomic value and commercial traction. First, prioritize investment in rigorous, replicated field trials that reflect diverse agroecological zones and application methods so that claims are robust and transferable. Second, align formulation development with channel realities by designing form types that suit mechanized application, fertigation systems, or retail handling requirements to minimize adoption friction. Third, diversify sourcing and enhance supplier partnerships to reduce exposure to tariff or supply disruptions while pursuing localized manufacturing where it improves responsiveness and cost control.

In parallel, strengthen regulatory and quality functions to ensure claims substantiation and label clarity across jurisdictions, and integrate digital data capture to document performance at scale for growers and distributors. Additionally, cultivate go-to-market collaborations with distributors, advisors, and ag-technology partners to embed products into integrated crop management programs. Finally, consider strategic portfolio balancing between innovative, higher-margin offerings and pragmatic, widely adoptable formulations that build recurring revenue streams. Taken together, these actions create a resilient platform for sustainable growth and reduce execution risk in a rapidly professionalizing sector.

A transparent mixed-methods research design combining primary stakeholder interviews, technical literature synthesis, and scenario evaluation to ensure defensible and actionable insights

The research approach underpinning these insights combined a multi-step methodology that balances primary validation with rigorous secondary synthesis. Primary inputs included structured interviews with growers, distributors, formulation specialists, and R&D leaders to capture on-the-ground practices, adoption barriers, and evidence requirements. These perspectives were triangulated with technical literature and peer-reviewed studies to validate modes of action and to understand formulation interactions across soil and foliar environments. In addition, regulatory frameworks and registration guidelines were reviewed to assess implications for claim substantiation and cross-border commercialization.

Analytical steps included cross-segmentation mapping to identify where form, source, application, and crop intersections create differentiated technical and commercial needs. Scenario evaluation techniques were applied to explore supply-chain and tariff sensitivities, and expert panels provided iterative validation of preliminary findings. Throughout the process, emphasis was placed on reproducible methods and transparent documentation of assumptions so that stakeholders can trace line-of-sight from evidence to recommendation. This mixed-methods approach yields a defensible interpretation of current dynamics and practical guidance for operational decision-making.

A strategic synthesis that emphasizes evidence-based commercialization, cross-functional alignment, and operational resilience as the determinants of long-term success

In conclusion, the current phase of the biostimulants sector is characterized by maturation of science, increasing regulatory expectations, and evolving commercial architectures that together raise both opportunity and execution requirements. Stakeholders that invest in rigorous validation, adaptable formulation strategies, and resilient sourcing will be better equipped to capture the strategic value that biostimulants can deliver in modern crop management systems. Moreover, alignment between R&D, regulatory, and commercial teams is essential to convert promising biological discoveries into products that growers can trust and adopt routinely.

Looking ahead, the sector's progress will hinge on continued improvements in evidence generation, clearer regulatory pathways, and stronger commercialization partnerships that integrate biostimulants into broader agronomic solutions. By focusing on reproducible benefits, operational scalability, and market-tailored approaches, organizations can navigate the complexity of the current landscape and position themselves for long-term relevance and impact within sustainable agriculture.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biostimulants Market, by Form

  • 8.1. Granule
  • 8.2. Liquid
  • 8.3. Powder

9. Biostimulants Market, by Source

  • 9.1. Amino Acids
  • 9.2. Humic Substances
    • 9.2.1. Fulvic Acid
    • 9.2.2. Humic Acid
  • 9.3. Microbial
    • 9.3.1. Actinomycetes
    • 9.3.2. Bacteria
    • 9.3.3. Fungi
  • 9.4. Protein Hydrolysates
    • 9.4.1. Animal Derived
    • 9.4.2. Plant Derived
  • 9.5. Seaweed Extract

10. Biostimulants Market, by Application Method

  • 10.1. Foliar
  • 10.2. Seed Treatment
  • 10.3. Soil Treatment
    • 10.3.1. Drip Irrigation
    • 10.3.2. Furrow Application

11. Biostimulants Market, by Crop Type

  • 11.1. Cereals & Grains
  • 11.2. Fruits & Vegetables
  • 11.3. Oilseeds & Pulses
  • 11.4. Turf & Ornamentals

12. Biostimulants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biostimulants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biostimulants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Biostimulants Market

16. China Biostimulants Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acadian Seaplants Limited
  • 17.6. Agricen by Nutrien
  • 17.7. AgriLife (India) Private Limited
  • 17.8. Agrinos
  • 17.9. Agritecno Fertilizantes SL
  • 17.10. Andermatt Group AG
  • 17.11. Apple Agro
  • 17.12. Atlantica Agricola, S.A.
  • 17.13. Axeb Biotech SL
  • 17.14. BASF SE
  • 17.15. Bayer AG
  • 17.16. BioAtlantis Ltd.
  • 17.17. Biobest Group NV
  • 17.18. BIOIBERICA S.A.U.
  • 17.19. Biolchim S.p.A. by J.M. Huber Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOSTIMULANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOSTIMULANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOSTIMULANTS MARKET SIZE, BY HUMIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ACTINOMYCETES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ACTINOMYCETES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ACTINOMYCETES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOSTIMULANTS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOSTIMULANTS MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOSTIMULANTS MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ANIMAL DERIVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOSTIMULANTS MARKET SIZE, BY ANIMAL DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PLANT DERIVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PLANT DERIVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOSTIMULANTS MARKET SIZE, BY PLANT DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FURROW APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FURROW APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FURROW APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CEREALS & GRAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CEREALS & GRAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOSTIMULANTS MARKET SIZE, BY CEREALS & GRAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS & PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS & PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS & PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOSTIMULANTS MARKET SIZE, BY TURF & ORNAMENTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOSTIMULANTS MARKET SIZE, BY TURF & ORNAMENTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOSTIMULANTS MARKET SIZE, BY TURF & ORNAMENTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIOSTIMULANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOSTIMULANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 169. GCC BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 170. GCC BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 194. G7 BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 196. G7 BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 197. G7 BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 203. NATO BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 205. NATO BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 206. NATO BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA BIOSTIMULANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA BIOSTIMULANTS MARKET SIZE, BY MICROBIAL, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)